Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 03:54 am EDT
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,655.06 million compared to CNY 1,206.86 million a year ago. Revenue was CNY 1,655.06 million compared to CNY 1,206.86 million a year ago. Net income was CNY 118.69 million compared to CNY 41.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.0701 compared to CNY 0.0247 a year ago. Diluted earnings per share from continuing operations was CNY 0.0701 compared to CNY 0.0247 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.